Abbott has initiated a medical device correction for sensors used in certain FreeStyle Libre 3 continuous glucose monitoring (CGM) systems in the US after determining that a number of them may be ...
The Food and Drug Administration has issued an alert concerning two glucose monitors with a “high-risk” sensor issue. Abbott Diabetes Care initiated a “medical device correction” on Nov. 24, for ...
This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health consequences or death. Anna Gragert (she/her/hers) was previously the ...
Diabetes patients and their families are raising concerns, and in some cases filing lawsuits, after Abbott Diabetes Care recalled glucose monitors linked to seven deaths. In December, Abbott recalled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results